Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases

Mihaela Farcaş, Zoran Gatalica, Kiril Trpkov, Jeffrey Swensen, Ming Zhou, Reza Alaghehbandan, Sean R. Williamson, Cristina Magi-Galluzzi, Anthony J. Gill, Maria Tretiakova, Jose I. Lopez, Delia Perez Montiel, Maris Sperga, Eva Comperat, Fadi Brimo, Asli Yilmaz, Farshid Siadat, Ankur Sangoi, Yuan Gao, Nikola PtákovaLevente Kuthi, Kristyna Pivovarcikova, Joanna Rogala, Abbas Agaimy, Arndt Hartmann, Cristoph Fraune, Boris Rychly, Pavel Hurnik, Dušan Durcansky, Michael Bonert, Georgios Gakis, Michal Michal, Milan Hora, Ondrej Hes

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

A distinct renal tumor has recently been described as “high-grade oncocytic renal tumor” and “sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm”. The Genitourinary Pathology Society (GUPS) consensus proposed a unifying name “eosinophilic vacuolated tumor” (EVT) for this emerging entity. In this multi-institutional study, we evaluated 19 EVTs, particularly their molecular features and mutation profile, using next-generation sequencing. All cases were sporadic and none of the patients had a tuberous sclerosis complex. There were 8 men and 11 women, with a mean age of 47 years (median 50; range 15–72 years). Average tumor size was 4.3 cm (median 3.8 cm; range 1.5–11.5 cm). All patients with available follow-up data (18/19) were alive and without evidence of disease recurrence or progression during the follow-up, ranging from 12 to 198 months (mean 56.3, median 41.5 months). The tumors were well circumscribed, but lacked a well-formed capsule, had nested to solid growth, focal tubular architecture, and showed ubiquitous, large intracytoplasmic vacuoles, round to oval nuclei, and prominent nucleoli. Immunohistochemically, cathepsin K, CD117, CD10, and antimitochondrial antigen were expressed in all cases. Other positive stains included: PAX8, AE1/AE3 and CK18. CK7 was typically restricted only to rare scattered cells. Vimentin, HMB45, melan-A, and TFE3 were negative in all cases. All tumors showed retained SDHB. All cases (19/19) showed non-overlapping mutations of the mTOR pathway genes: TSC1 (4), TSC2 (7), and MTOR (8); one case with MTOR mutation showed a coexistent RICTOR missense mutation. Low mutational rates were found in all samples (ranged from 0 to 6 mutations/Mbp). Microsatellite instability and copy number variations were not found in any of the 17 analyzable cases. EVT represents an emerging renal entity that shows a characteristic and readily identifiable morphology, consistent immunohistochemical profile, indolent behavior, and mutations in either TSC1, TSC2, or MTOR genes.

Original languageEnglish
Pages (from-to)344-351
Number of pages8
JournalModern Pathology
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2022

Field of Science*

  • 3.1 Basic medicine
  • 3.2 Clinical medicine

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases'. Together they form a unique fingerprint.

Cite this